Rybelsus vs Ozempic: Pill vs Injection for Diabetes

Same active ingredient, different delivery methods — two separate FDA-approved products.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Rybelsus vs Ozempic is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated June 2026Medically reviewed by licensed providers

Rybelsus vs Ozempic: both are FDA-approved GLP-1 medications for weight loss. Rybelsus (semaglutide) and Ozempic (semaglutide) differ in mechanism and clinical efficacy. Weight Method offers both from $199/month with virtual consultations and licensed providers.

Overview

Rybelsus and Ozempic are two separate FDA-approved products that both contain semaglutide from Novo Nordisk for type 2 diabetes, differing in delivery method. Ozempic is a once-weekly subcutaneous injection (0.25–2 mg) approved in 2017, while Rybelsus is a once-daily oral tablet (3–14 mg) approved in 2019. The oral form requires specific dosing conditions — taken on an empty stomach with a small amount of water, followed by a 30-minute fast — because oral semaglutide has lower bioavailability than the injectable form. Weight Method does not dispense or prescribe either brand-name product; our program provides compounded semaglutide through licensed providers and U.S.-licensed pharmacies. Which option is appropriate for you is a decision made by a licensed provider based on your individual medical profile.

Key Fact

Rybelsus (oral, up to 14 mg) and Ozempic (injectable, up to 2 mg) both contain semaglutide and are FDA-approved for type 2 diabetes. They differ in delivery route and dosing. Both are products of Novo Nordisk and are different from Weight Method's compounded program.

Source: FDA prescribing information (Rybelsus; Ozempic)

Rybelsus

ManufacturerNovo Nordisk
Active Ingredientsemaglutide
FDA IndicationType 2 diabetes
FDA Approval2019
FormulationOral tablet
FrequencyOnce daily
Available Doses3mg, 7mg, 14mg
Avg. Weight Loss5-10%
Our Price$199/mo

Ozempic

ManufacturerNovo Nordisk
Active Ingredientsemaglutide
FDA IndicationType 2 diabetes
FDA Approval2017
FormulationInjectable pen
FrequencyOnce weekly
Available Doses0.25mg, 0.5mg, 1mg, 2mg
Avg. Weight Loss10-15%
Our Price$199/mo

Key Differences

Rybelsus and Ozempic contain the same active ingredient and are both FDA-approved for type 2 diabetes; the difference is the delivery route (daily oral tablet vs. weekly injection) and the associated dosing and administration requirements. The mechanism class — GLP-1 receptor agonist — is the same. Which option is clinically appropriate for any individual depends on that person's medical history and preferences and is determined by a licensed provider. Both are different from Weight Method's compounded semaglutide, priced at $154/mo.

Verdict

Rybelsus and Ozempic are distinct FDA-approved branded products from Novo Nordisk that differ in delivery route; neither is what Weight Method dispenses. The right option for an individual depends on that person's medical profile and preferences and is determined by a licensed provider. Weight Method's compounded semaglutide is available at $154/mo.

Ready to Get Started?

Answer a few quick questions to see if you qualify for GLP-1 medication.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Both contain semaglutide and are FDA-approved for type 2 diabetes; the difference is the delivery route — Rybelsus is a daily oral tablet and Ozempic is a weekly injection — along with their respective dosing and administration requirements. Which one is appropriate for a given person is a clinical decision made by a licensed provider based on their individual medical profile.

Delivery-route preference is a common factor — some patients prefer a daily pill over a weekly injection, while others prefer the opposite. Whether a particular formulation is appropriate for an individual is determined by a licensed provider based on that person's medical profile and preferences.

Any change between formulations should occur under medical supervision, and Weight Method dispenses neither brand-name product. Whether a transition is appropriate and how dosing is managed is determined by a licensed provider based on your individual medical profile and response.

Rybelsus is typically taken first thing in the morning on a completely empty stomach with no more than 4 ounces of plain water, waiting at least 30 minutes before eating, drinking anything else, or taking other oral medications. Follow the specific instructions given by your licensed provider.

The side effect profiles are similar — nausea, diarrhea, vomiting, and decreased appetite are most common with both. Ozempic may cause injection site reactions, while Rybelsus can cause additional stomach-specific discomfort related to the oral absorption enhancer in the tablet formulation. A licensed provider monitors tolerability for patients in Weight Method's compounded program.

Ready to Get Started?

Take our 2-minute quiz to see if you qualify for GLP-1 treatment.

Start Quiz

Free consultation. No commitment.

Related Brand Pages

More Comparisons